Dividend criteria checks 0/6
Celularity Inc. does not have a record of paying a dividend.
|Industry average yield||2.5%|
|Next dividend pay date||n/a|
|Ex dividend date||n/a|
|Dividend per share||US$0|
|Earnings per share||-US$0.098|
|Dividend yield forecast in 3Y||n/a|
Recent dividend updates
Celularity appoints Adrian Kilcoyne as chief medical officerOct 03
Celularity falls after announcing fund raising dealSep 15
Celularity falls 10% on deal for $150M common stock offeringSep 08
Celularity begins phase 1/2a trial for cell therapy CYNK-101 to treat cancersJul 27
News Flash: Analysts Just Made A Massive Upgrade To Their Celularity Inc. (NASDAQ:CELU) ForecastsDec 14
Celularity: Celgene Spin-Off Developing Allogeneic TherapiesSep 06
Stability and Growth of Payments
|Month||Dividend Per Share (annual)||Avg. Yield (%)|
Stable Dividend: Insufficient data to determine if CELU's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CELU's dividend payments have been increasing.
Dividend Yield vs Market
|Celularity Dividend Yield vs Market|
|Market Bottom 25% (US)||1.5%|
|Market Top 25% (US)||4.2%|
|Industry Average (Biotechs)||2.5%|
|Analyst forecast in 3 Years (CELU)||n/a|
Notable Dividend: Unable to evaluate CELU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CELU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CELU has not reported any payouts.